In triple-negative breast cancer, oleuropein inhibits cell migration and invasion induced by HGF through autophagy by upregulation of LC3-II/LC3-I and Beclin-1, as well as downregulation of p62 [68]. The gene discussed is BECN1; the disease is triple-negative breast carcinoma.